Ask A Lawyer
Contact Us
RegisterPatent Protection for Chinese Technology Companies in Israel: Prosecution, Enforcement, and Technology Transfer Strategy
Israel has become a significant source of deep technology for Chinese investors, particularly in agritech, water technology, medical devices, and cybersecurity. Understanding Israel's patent framework under the Patents Law 5727-1967 is essential for Chinese companies seeking to protect and commercialize their innovations in Israel.
Patent Prosecution Under Israeli Law
The Israel Patent Office operates under the Patents Law 5727-1967, which has been modernized through successive amendments to align with international standards. The Israeli patent system follows the first-to-file principle and grants patent protection for 20 years from the filing date. Patentable subject matter includes products, processes, and uses, with exclusions for mathematical methods, business methods, and therapeutic treatment methods. Israeli patent law provides a one-year grace period for disclosures by the inventor or derived from the inventor, which differs from the absolute novelty requirement in many other jurisdictions. Examination at the Israel Patent Office includes a prior art search and substantive examination. The average time from filing to grant is three to five years, depending on the technology field and examination workload.
Patent Prosecution Highway (PPH)
The Israel Patent Office participates in the Patent Prosecution Highway with the USPTO, JPO, and KIPO. Under the PPH program, applicants whose claims have been found allowable by a participating office may request accelerated examination of corresponding Israeli applications, reducing prosecution time and examination costs. Chinese companies with existing Chinese patent applications may also benefit from the PPH framework through Israel's bilateral PPH arrangements. Practical experience has shown that PPH requests at the Israel Patent Office are processed within two to four months, compared to 12-18 months for standard examination requests.
Patent Term Extension
Patent term extension is available under Israeli law for pharmaceutical and medical device patents where regulatory approval by the Ministry of Health has caused commercialization delays. The extension period compensates for the time between the patent grant date and the regulatory approval date, subject to a maximum extension of five years. Chinese pharmaceutical companies seeking to commercialize approved drugs in Israel should identify relevant patent term extension opportunities at an early stage of regulatory planning.
Technology Transfer and Licensing
Technology transfer from Israel to China is governed by a combination of Israeli contract law, patent law, and regulatory oversight for certain sectors such as defense and cybersecurity. Cross-border licensing agreements typically address royalty calculations, territorial scope, sublicensing rights, grant-back provisions on improvements, and dispute resolution mechanisms. For technology originating from Israeli academic institutions, the Technology Transfer Company (TTC) framework governs how university-derived intellectual property is commercialized, including equity participation, royalty sharing, and research sponsorship terms.
Industrial Design Protection
Industrial design registration in Israel is available through the Israel Patent Office for product designs that are novel and have individual character. Unregistered design protection is also available for three years from first disclosure. Plant variety protection is administered separately through the Ministry of Agriculture. Utility model protection is not available in Israel, meaning that incremental innovations require full patent protection. Chinese agricultural and biotechnology investors should plan their Israeli IP strategy accordingly, filing full patent applications rather than relying on utility model equivalents that do not exist in Israeli law.
Trade Secret Protection
Israeli law protects trade secrets under the Commercial Torts Law 5759-1999. Protection requires that the information be secret, have commercial value, and be subject to reasonable confidentiality steps. Chinese technology investors should implement confidentiality agreements with Israeli partners, employee invention assignment provisions, access controls, and technology transfer documentation. Enforcement options include preliminary injunctions, damages claims, and account-of-profits remedies available through the Israeli district courts. Trade secret litigation in Israel is conducted in camera where necessary to protect the confidentiality of the information at issue.
Patent Cooperation Treaty Filings
Chinese applicants seeking patent protection in Israel may file through the Patent Cooperation Treaty route, designating Israel as a national phase entry within 31 months from the priority date. The PCT route provides additional time for evaluating commercial viability of the Israeli market before committing to translation, filing fees, and local agent costs. Israeli national phase entry requires a Hebrew translation of the patent specification (or English for certain applications) and payment of examination fees. The Israel Patent Office participates in the PCT-PPH program allowing accelerated examination where claims have been found allowable by another PCT authority.
IP Strategy for Chinese-Israeli Collaboration
Chinese companies entering joint ventures with Israeli technology partners require comprehensive IP allocation provisions covering background IP ownership, foreground IP allocation, joint ownership rights including enforcement and licensing, confidentiality before and after termination, and territorial restrictions. Israeli technology companies often hold US and European patents in addition to Israeli patents, requiring global portfolio management provisions including prosecution cost sharing, enforcement decision-making, and revenue sharing from licensing or sale of jointly developed IP. Dispute resolution clauses should specify the governing law and forum for IP-related disagreements.
Patent Enforcement and Border Measures
Israeli customs authorities maintain a recordal system for registered patents, allowing rights holders to request border detention of suspected infringing goods. Customs recordal applications require proof of patent registration, a description of the authentic product, and a bank guarantee for potential damages if the detention is found unjustified. The customs recordal procedure provides a cost-effective enforcement mechanism that supplements court proceedings, particularly where infringing goods are identified being imported through Israeli ports.
Cross-Border IP Licensing Framework
Technology transfer from Israel to China is regulated by Israeli export control laws administered by the Ministry of Economy and the Ministry of Defense, which impose licensing requirements for the transfer of specified controlled technologies to foreign entities. Chinese investors should conduct a technology classification audit to determine whether the proposed Israeli technology is subject to export control restrictions. The Israel-China tax treaty provides withholding tax rates on patent royalties. Licensing agreements should specify the tax treatment of royalty payments.
Patent Term Extension Opportunities
Patent term extension is available under Israeli law for pharmaceutical and medical device patents affected by regulatory approval delays. Chinese pharmaceutical companies should identify patent term extension opportunities early in the regulatory planning process. The extension period compensates for the time between patent grant and regulatory approval from the Ministry of Health, subject to a maximum of five years. The patent must be the first approval for the active ingredient, and only one extension per product is available. Pediatric extensions provide an additional six months where clinical trials have been conducted in the pediatric population.
Practical Procedure for Chinese Applicants
Chinese companies seeking patent protection in Israel should engage Israeli patent attorneys registered with the Israel Patent Office to prepare and prosecute applications. The patent specification must be filed in Hebrew or English, with a Hebrew translation required for grant if the application was filed in English. Filing can proceed through the Paris Convention route claiming priority from a Chinese patent application within twelve months, or through the Patent Cooperation Treaty route with national phase entry within thirty-one months. Official fees include filing fees, examination fees, and grant fees. Annual renewal fees must be paid to maintain the patent in force, starting from the second year after filing.
Enforcement Against Third Party Infringement
Patent infringement in Israel is addressed through civil proceedings in the Tel Aviv District Court. The court may grant preliminary injunctions before trial where the patentee demonstrates a prima facie case of infringement and that the balance of convenience favors interim relief. At trial, the patentee must prove infringement on a balance of probabilities and may be required to defend the validity of the patent against invalidity counterclaims. Damages calculation considers the actual loss suffered by the patentee, the profits earned by the infringer, or a reasonable royalty. The prevailing party is typically awarded legal costs. Appeals from the District Court proceed to the Supreme Court of Israel.
